Manufacturer
NOVARTIS CONSUMER HEALTH S.A.
Contents
Terbinafine
Indication
Fungal infections of the skin caused by dermatophytes, yeast & pityriasis versicolor.
Instruction
Adult: As 1% cream/gel/spray: Apply once or bid to affected area(s). Treatment duration: 1-2 wk (tinea corporis, tinea cruris), 1 wk (tinea pedis), 2 wk (cutaneous candidiasis and pityriasis).
Drug interaction
Increased serum concentration w/ cimetidine, CYP450 inhibitors (e.g. fluconazole, amiodarone, ketoconazole). Decreased serum concentration w/ rifampicin. May increase plasma concentration of TCA(s), β-blockers, SSRIs, antiarrythmics, MAOI(s) type B. May cause menstrual disturbances (e.g. breakthrough bleeding, irregular cycle) w/ OC. May decrease clearance of esipramine.
Malaysia
